19-40273885-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001626.6(AKT2):c.-84-8534G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.114 in 152,154 control chromosomes in the GnomAD database, including 1,431 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.11 ( 1431 hom., cov: 31)
Consequence
AKT2
NM_001626.6 intron
NM_001626.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -6.36
Publications
3 publications found
Genes affected
AKT2 (HGNC:392): (AKT serine/threonine kinase 2) This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains, which is involved in signaling pathways. The gene serves as an oncogene in the tumorigenesis of cancer cells For example, its overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins, and has also been implicated in insulin signaling. [provided by RefSeq, Nov 2019]
AKT2 Gene-Disease associations (from GenCC):
- hypoinsulinemic hypoglycemia and body hemihypertrophyInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- diabetes mellitus, noninsulin-dependentInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- AKT2-related familial partial lipodystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- type 2 diabetes mellitusInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.225 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AKT2 | NM_001626.6 | c.-84-8534G>A | intron_variant | Intron 1 of 13 | ENST00000392038.7 | NP_001617.1 | ||
| AKT2 | NM_001243027.3 | c.-233-8534G>A | intron_variant | Intron 1 of 13 | NP_001229956.1 | |||
| AKT2 | NM_001243028.3 | c.-141+11296G>A | intron_variant | Intron 1 of 12 | NP_001229957.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AKT2 | ENST00000392038.7 | c.-84-8534G>A | intron_variant | Intron 1 of 13 | 1 | NM_001626.6 | ENSP00000375892.2 |
Frequencies
GnomAD3 genomes AF: 0.114 AC: 17295AN: 152036Hom.: 1430 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
17295
AN:
152036
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.114 AC: 17312AN: 152154Hom.: 1431 Cov.: 31 AF XY: 0.112 AC XY: 8326AN XY: 74406 show subpopulations
GnomAD4 genome
AF:
AC:
17312
AN:
152154
Hom.:
Cov.:
31
AF XY:
AC XY:
8326
AN XY:
74406
show subpopulations
African (AFR)
AF:
AC:
9488
AN:
41474
American (AMR)
AF:
AC:
1079
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
271
AN:
3472
East Asian (EAS)
AF:
AC:
270
AN:
5170
South Asian (SAS)
AF:
AC:
310
AN:
4822
European-Finnish (FIN)
AF:
AC:
576
AN:
10614
Middle Eastern (MID)
AF:
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4967
AN:
68000
Other (OTH)
AF:
AC:
233
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
737
1475
2212
2950
3687
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
264
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.